SHARE THIS ARTICLE:
NEW: Hopkins Psilocybin Lyme Study: Baltimore Area
Johns Hopkins Center for Psychedelic & Consciousness Research announced in its Summer 2022 Newsletter a new study opportunity. Patients suffering from Post-Treatment Lyme Disease in the Baltimore area who continue to experience symptoms such as widespread pain, fatigue, or cognitive issues after completing treatment are invited to apply to participate in a Johns Hopkins-approved research study that is designed to determine whether the psychedelic drug, psilocybin, when administered under supportive conditions, can be helpful in alleviating the burden of ongoing symptoms.
This study is unpaid and requires a considerable time commitment to the following:
- One to two in-person screenings,
- One to two weekly meetings over the course of eight weeks,
- Two supervised onsite moderate-dose psilocybin sessions, and,
- Three supplemental meetings within the six months that follow treatment.
Because of the significant time commitment required for the study, patients who live outside of the Baltimore area will generally not be considered.
Click here to apply for the study or call 443-470-6189 to learn more.
Principal Investigator: Albert Garcia-Romeu, Ph.D.; Protocol: IRB00281685
Read the announcement from Johns Hopkins Center for Psychedelic & Consciousness Research.
More Information
Read more about Post Treatment Lyme Disease:
A New Look at Chronic Lyme by Pamela Weintraub
New Study: Persistent Symptoms After Early Diagnosis & Treatment for Lyme Disease
Spirochete Persists After Lyme Treatment.